CASE PRESENTATION
The patient was a 33-year-old man with HCC and liver cirrhosis caused by chronic hepatitis B virus infection. Multiple nodular type HCC was diagnosed based on high serum α-fetoprotein (AFP) level (3,296 ng/mL; normal < 20 ng/mL) [5] and imaging studies [6] in December 2004. He received three sessions of transcatheter arterial chemoembolization and one session of percutaneous pure ethanol injection for the management of HCC. The functional reserve of liver cirrhosis was maintained in Child-Pugh class A. Serum AFP level returned to within normal range after this treatment, but it rebounded to 165.9 ng/mL on March 22, 2006.
Serial imaging studies including whole body bone scan, chest X-ray, abdominal ultrasonography, magnetic resonance imaging and angiography were performed to detect the possibility of recurrent HCC. However, no definite viable HCC was found. The serum AFP level increased to 422 ng/mL on June 7, 2006 . The condition of the patient was quite satisfactory until June 25, 2006 when he suffered severe abdominal pain and was sent to our emergency department. The characteristics of the pain were dull, radiating to the back, aggravated by food intake and relieved by bed rest. The location of the pain was around the epigastric area. Physical examination showed diffuse abdominal tenderness, diminished bowel sounds but no rebounding pain or fever. Laboratory data showed serum C-reactive protein 15.32 μg/ mL (normal < 5 μg/mL), amylase 308 U/L (normal < 123 U/L), lipase 284 IU/L (normal < 58 IU/L), aspartate aminotransferase 51 U/L (normal < 35 U/L), alanine aminotransferase 66 U/L (normal < 92 U/L), total bilirubin 2.13 mg/dL (normal < 1.11 mg/dL), and conjugated bilirubin 1.17 mg/dL (normal < 0.4 mg/dL). The coagulation profile was: prothrombin time, 11.6 seconds/10.7 seconds (control); international normalized ratio, 1.05; partial prothrombin time, 33.4 seconds/ 30.1 seconds (control).
Under the impression of acute pancreatitis, contrastenhanced computed tomography (CT) was performed. Peripancreatic fluid collection around the pancreatic head was found, which supported the diagnosis of pancreatitis. Moreover, CT also showed deposition of lipiodol caused by previous transcatheter arterial chemoembolization in segments 3 and 6 by Couinaud Segmental Classification [7] , suspected dysplastic nodules in segments 5 and 6 [7] , liver cirrhosis with splenomegaly, gallbladder stones, main portal trunk thrombosis, and ascites ( Figure 1) .
He was admitted to our institution for the treatment of acute pancreatitis. The general condition of the patient improved rapidly after conservative management and he was discharged 9 days later. Reserve liver function did not deteriorate during admission. The main portal trunk thrombosis was not treated because thrombosis was considered to be caused by local inflammation during the episode of pancreatitis and observation was advised.
Unfortunately, he suffered from another similar episode of severe abdominal pain on August 10, 2006. The characteristics of the pain were dull, radiating to the back, aggravated by food intake and relieved by bed rest. The location of the pain was around the epigastric area. Physical examination showed diffuse abdominal tenderness, decreased bowel sounds but no rebounding pain or fever. Laboratory data showed an elevated serum lipase level (215 IU/L). Under the impression of acute pancreatitis, contrast-enhanced CT was again performed. Compared to the previous study, the amount of ascites had slightly increased. The sizes of the hepatic nodules remained unchanged and the main portal trunk was free of thrombosis ( Figure 2 ). He was admitted to our institution for conservative treatment of acute pancreatitis and discharged 7 days later.
DISCUSSION
Liver cirrhosis plays an important role in adult patients with PVT. Splenomegaly, wide main portal trunk, high portal venous pressure and the terminal stage of liver function are reported to be risk factors for the development of PVT in patients with cirrhosis [8, 9] . However, the actual mechanism for the development of PVT in patients with cirrhosis still needs to be clarified [10] . It has been reported that a decrease in portal blood flow and the presence of peripheral lymphangitis and fibrosis may be associated with the development of PVT [11] . Reduced liver synthetic activity made the coagulation and anticoagulation factors abnormal in patients with liver cirrhosis [12] . Abnormality in coagulation can be a precipitating factor for the development of PVT.
Neoplasm is another important cause of the development of PVT. Among malignancies causing PVT, HCC and pancreatic carcinoma are the two most frequent causes [13] . The mechanisms for the development of PVT in malignancy can be due to the invasion of cancer cells to the portal lumen, compression of the portal vein by tumor burden, or by neoplasm-related prothrombotic changes [14] .
Management of PVT should be based on its etiology and the condition of the patient. Spontaneous resolution of PVT caused by benign etiology is possible but uncommon [13] . Anticoagulation therapy is recommended for the treatment of acute benign PVT as complete or partial resolution can be achieved in up to 80% of patients [15] . Heparin and tissue-type plasminogen activator (t-PA) are used in most studies [15] [16] [17] . Anticoagulation may not increase the risk of bleeding but reduces that of mesenteric infarction, which is possibly life-threatening. However, systemic anticoagulation therapy may be unsuitable for cirrhotic patients with severe abnormality in coagulation. Thrombolysis through a transhepatic route is another choice for the treatment of acute benign PVT to avoid the adverse effects of systemic anticoagulant therapy [17] [18] [19] . This is an invasive management and carries the risk of intraabdominal hemorrhage or hemobilia. The management of PVT caused by malignancy is quite different from that used for the management of benign PVT. The resolution of malignant PVT can be achieved only when the involved cancer cells can be well treated. Systemic chemotherapy, local irradiation therapy, or transcatheter arterial chemoembolization are choices for the management of malignant PVT. However, each of the above carries its own side effects and cannot be applied to all patients with malignant PVT.
The case presented above had HCC and cirrhosis, both of which could possibly develop to PVT. Progressive increase in serum AFP levels during the followup period strongly suggested recurrence of HCC. Therefore, new-onset PVT detected by CT was reasonably considered to be malignant in origin. However, the location of PVT was in the main trunk. There was no detectable hepatofugal portal flow in imaging studies and the other parts of the portal system were completely free of thrombosis. The locations of all treated HCC nodules and the suspected dysplastic nodules were far away from the main trunk thrombus. There was also no detectable tumor burden around the main portal trunk. PVT in this case was not considered to be caused by HCC. On the other hand, the possibility of PVT caused by cirrhosis could not be completely excluded. However, this case did not have past history of abnormality in coagulation. Sudden onset of thrombosis located only in part of the main trunk was not easily explained by the reason of abnormality in coagulation. Pancreatitis is a possible etiology of PVT. The mechanism is suggested to be either portal venous compression caused by pseudocyst or abscess, or an imbalance between blood coagulation and fibrinolysis [19] . Portal phlebitis caused by leakage of pancreatic juice around the portal vein may also be a factor in the development of PVT in pancreatitis. The location of thrombus in this case was surrounded by the fluid induced by the episode of pancreatitis. Formation of thrombus caused by local phlebitis was the most reasonable explanation in this case. PVT can elevate the portal pressure which had the potential to cause rupture of esophageal or cardiac varices. In this case, we did not examine the change in portal pressure or varices during admission, because there was no evidence of gastrointestinal hemorrhage to support the necessity of performing further examination. We did not treat the PVT and chose close observation instead. Disappearance of thrombus soon after recovery from acute pancreatitis confirmed that PVT was caused by the inflammatory process. The second episode of acute pancreatitis did not show evidence of PVT. This could be explained by fluid collection around the main trunk in the second episode being much less than that in the first episode. Two episodes of acute pancreatitis could be successfully treated by a conservative approach. No obvious cause of pancreatitis could be identified by imaging studies, patient drug abuse history, or laboratory data. Although the imaging studies did not show any evidence of biliary stones, according to the clinical course of this patient, pancreatitis caused by passage of common bile stones combined with or without cholangitis was the most likely etiology.
In conclusion, PVT can be caused by pancreatitis. Control of the underlying disease may be the first choice for treatment of this kind of PVT. Development of PVT in a patient with HCC and cirrhosis necessarily originates from one of these two possible etiologies and the other possibilities should also be considered. 
